Table 4.
Numbers and percentages of patients with spontaneously reported adverse events, reported by 5% or more of subjects; no statistically significant difference between treatment groups.
| Placebo n (%) | Triiodothyronine n (%) | Total n (%) | |
|---|---|---|---|
| Headache | 40 (53.3) | 42 (55.2) | 82 (54.3) |
| Diarrhea | 23 (30.6) | 18 (23.7) | 41 (27.2) |
| Nausea | 22 (29.3) | 13 (17.1) | 35 (23.2) |
| Insomnia | 21 (28) | 13 (17.1) | 34 (22.5) |
| Dry Mouth | 15 (20) | 12 (15.8) | 27 (17.9) |
| Stomach Discomfort | 15 (20) | 10 (13.2) | 25 (16.6) |
| Fatigue | 12 (16) | 11 (14.5) | 23 (15.2) |
| Tremulousness | 13 (17.3) | 5 (6.6) | 18 (11.9) |
| Sweating | 10 (13.3) | 7 (9.2) | 17 (11.3) |
| Sedation | 6 (8) | 9 (11.8) | 15 (9.9) |
| Constipation | 4 (5.3) | 9 (11.8) | 13 (8.6) |
| Feeling Jittery | 8 (10.6) | 5 (6.6) | 13 (8.6) |
| Urination Increased | 7 (9.3) | 6 (7.9) | 13 (8.6) |
| Palpitations | 7 (9.3) | 5 (6.6) | 12 (7.9) |
| Libido Decreased | 3 (4) | 8 (10.5) | 11 (7.3) |
| URI | 7 (9.3) | 4 (5.3) | 11 (7.3) |
| Change in Attention | 3 (4) | 7 (9.2) | 10 (6.6) |
| Chest Pain | 7 (9.3) | 2 (2.6) | 9 (6) |
| Flatulence | 5 (6.6) | 4 (5.3) | 9 (6) |
| Anxiety | 8 (10.6) | 0 (0) | 8 (5.3) |
| Feeling Hot | 5 (6.6) | 3 (3.9) | 8 (5.3) |
| Muscle Cramps | 3 (4) | 5 (6.6) | 8 (5.3) |